AB0676 Efficacy of rituximab therapy against anti-neutrophil cytoplasmic antibody-related hypertroph...
AB0676 Efficacy of rituximab therapy against anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis: a case series
About this item
Full title
Author / Creator
Kobayashi, K. , Nakagomi, D. , Hanai, S. , Yamagata, M. , Sugiyama, T. , Kawashima, H. , Hiraguri, M. , Kasuya, T. , Furuta, S. , Ikeda, K. , Nakajima, H. and Kitamura, K.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis presents with various symptoms. ANCA-associated hypertrophic pachymeningitis (HP) is a very rare pathology.ObjectivesThis study aimed to investigate the efficacy of rituximab (RTX) against patients with ANCA-related HP.MethodsSeven patients were identified by retrospective...
Alternative Titles
Full title
AB0676 Efficacy of rituximab therapy against anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis: a case series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071164562
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071164562
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.5345
